Amgen (AMGN) PT Lowered to $292 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures sink as Amazon, Intel intensify AI spending fears
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $460.73 --0%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 37 | New: 6
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 37 | New: 6
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Amgen (NASDAQ: AMGN) to $292.00 (from $294.00) while maintaining a Outperform rating.
You May Also Be Interested In
- FDA: Amgen Vectibix promotional video found false or misleading
- Amgen's dazodalibep shows positive Phase 3 results in Sjögren's
- Samsung C&T Corp (028260:KS) PT Lowered to KRW500,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
